Intellia Therapeutics Inc.

In News

Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM - ir.intelliatx.com

ir.intelliatx.com - Mar 02, 2026

Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory - Yahoo Finance

Yahoo Finance - Feb 28, 2026

Intellia Therapeutics to resume dosing of gene therapy in Phase III trial - clinicaltrialsarena.com

clinicaltrialsarena.com - Jan 28, 2026

Intellia Therapeutics (NTLA) — Vanguard disaggregates holdings, parent reports 0 shares - Stock Titan

Stock Titan - Mar 27, 2026

Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN - ir.intelliatx.com

ir.intelliatx.com - Jan 27, 2026

Baird Updates Intellia Therapeutics, Inc. (NTLA)’s Financial Model Following Nex-Z Clinical Hold Removal - Yahoo Finance

Yahoo Finance - Feb 02, 2026

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates - ir.intelliatx.com

ir.intelliatx.com - Nov 06, 2025

Intellia Therapeutics, Inc. (NTLA): A Bear Case Theory - Yahoo Finance

Yahoo Finance - Dec 04, 2025

Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2025 Financial Results and Business Updates - ir.intelliatx.com

ir.intelliatx.com - Feb 19, 2026

A Look At Intellia Therapeutics (NTLA) Valuation After Its Recent Share Price Rebound - Yahoo Finance

Yahoo Finance - Mar 05, 2026

Intellia Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - ir.intelliatx.com

ir.intelliatx.com - Jan 07, 2026

Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z) - ir.intelliatx.com

ir.intelliatx.com - Oct 27, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment